{"id":"W4290996954","doi":"10.1136/annrheumdis-2022-eular.1070","title":"POS0082 A NOVEL PSORIATIC ARTHRITIS COMPOSITE ENDPOINT COMBINING TREATMENT TARGETS FOR SKIN AND JOINTS: POOLED RESULTS FROM THE GUSELKUMAB DISCOVER-1 AND DISCOVER-2 STUDIES","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; University of Calgary","funders":"UCB Pharma; Regeneron Pharmaceuticals; Celgene; Gilead Sciences; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Secukinumab; Psoriasis; Dermatology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007418367,0.002542769,0.007195494,0.001016086,0.0003187684,0.002237128,0.0007621708,0.001364305,0.003271367],"category_scores_gemma":[0.005205507,0.000691942,0.0129703,0.001463831,0.0004818279,0.001491022,0.001181795,0.002860658,0.0007434686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005886797,"about_ca_system_score_gemma":0.000690892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007698683,"about_ca_topic_score_gemma":0.002446989,"domain_scores_codex":[0.9959604,0.002116535,0.0004077098,0.0006654445,0.0006027721,0.0002470848],"domain_scores_gemma":[0.996877,0.0015945,0.0006784291,0.0003694551,0.0002794999,0.0002010983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5640264,0.0004983848,0.02340504,0.01326332,0.2999723,0.0002067781,0.00009646107,0.003777337,0.008115815,0.0005207699,0.006655418,0.07946204],"study_design_scores_gemma":[0.1570285,0.02722667,0.127187,0.00139638,0.6614255,0.0006665688,0.0002292534,0.003996304,0.003597265,0.002925235,0.01396993,0.0003514055],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6913151,0.2625212,0.009361166,0.001406007,0.00220684,0.0009100646,0.01940257,0.0006268493,0.01225018],"genre_scores_gemma":[0.9603561,0.0205282,0.002441533,0.001436266,0.001211662,0.0006468394,0.01057953,0.0001493939,0.00265037],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007418367,"threshold_uncertainty_score":0.03923255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04774416423755114,"score_gpt":0.28385856135729,"score_spread":0.2361143971197388,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}